Banca Mediolanum (BMED) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Jun, 2026Executive summary
Net income for H1 2024 reached €449.9 million, up 24% year-over-year, driven by higher net interest and commission income, strong market performance, and record customer acquisition.
Assets under administration and management rose to €129.5 billion, a 15% increase year-over-year and up 10% from year-end 2023, supported by robust net inflows and favorable markets.
Customer acquisition set a new record with an 8% increase year-over-year, including 16,100 new digital customers and expansion of the Family Banker network.
Maintained a simple, solid balance sheet and robust capital position, supporting growth and shareholder returns.
Operating margin improved 22% to €566.1 million, with positive contributions across all business segments.
Financial highlights
Net commission income rose 15% year-over-year to €587.4 million, driven by higher average AUM and recurring commissions.
Net interest income increased 20% to €418 million, benefiting from higher rates and increased lending.
Total net inflows grew 21% to €5.66 billion; managed asset inflows up 43% to €3.09 billion.
Cost/income ratio improved to 39.2% (from 41.2% in H1 2023).
Credit book stable at €16.95 billion.
Outlook and guidance
Net inflows into managed assets expected between €6.5–7 billion for 2024, revised up from previous guidance.
Net interest income for 2024 forecast to grow ~10% year-over-year, expected to be flat in 2025.
Cost/income ratio and cost of risk expected to remain around 40% and ~20bps, respectively.
Dividend expected to increase year-over-year, supported by high capital ratios.
Continued focus on customer acquisition, digital expansion, and network development to drive medium-term AUM growth.
Latest events from Banca Mediolanum
- Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20252 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Q1 2026 net income up 13%, with strong margins, inflows, and robust capital ratios.BMED
Q1 20267 May 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025